1. Home
  2. ABVE vs MGNX Comparison

ABVE vs MGNX Comparison

Compare ABVE & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVE
  • MGNX
  • Stock Information
  • Founded
  • ABVE 2019
  • MGNX 2000
  • Country
  • ABVE Canada
  • MGNX United States
  • Employees
  • ABVE N/A
  • MGNX N/A
  • Industry
  • ABVE Packaged Foods
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABVE Consumer Staples
  • MGNX Health Care
  • Exchange
  • ABVE Nasdaq
  • MGNX Nasdaq
  • Market Cap
  • ABVE 108.5M
  • MGNX 94.9M
  • IPO Year
  • ABVE N/A
  • MGNX 2013
  • Fundamental
  • Price
  • ABVE $2.58
  • MGNX $1.50
  • Analyst Decision
  • ABVE
  • MGNX Hold
  • Analyst Count
  • ABVE 0
  • MGNX 5
  • Target Price
  • ABVE N/A
  • MGNX $3.20
  • AVG Volume (30 Days)
  • ABVE 2.0M
  • MGNX 881.4K
  • Earning Date
  • ABVE 01-01-0001
  • MGNX 11-12-2025
  • Dividend Yield
  • ABVE N/A
  • MGNX N/A
  • EPS Growth
  • ABVE N/A
  • MGNX N/A
  • EPS
  • ABVE N/A
  • MGNX N/A
  • Revenue
  • ABVE $213,446,206.00
  • MGNX $127,626,000.00
  • Revenue This Year
  • ABVE N/A
  • MGNX N/A
  • Revenue Next Year
  • ABVE N/A
  • MGNX N/A
  • P/E Ratio
  • ABVE N/A
  • MGNX N/A
  • Revenue Growth
  • ABVE N/A
  • MGNX N/A
  • 52 Week Low
  • ABVE $0.25
  • MGNX $0.99
  • 52 Week High
  • ABVE $6.56
  • MGNX $3.77
  • Technical
  • Relative Strength Index (RSI)
  • ABVE 47.78
  • MGNX 46.92
  • Support Level
  • ABVE $1.84
  • MGNX $1.33
  • Resistance Level
  • ABVE $2.47
  • MGNX $1.64
  • Average True Range (ATR)
  • ABVE 0.38
  • MGNX 0.11
  • MACD
  • ABVE 0.00
  • MGNX 0.00
  • Stochastic Oscillator
  • ABVE 55.03
  • MGNX 42.70

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: